S&P 500 Consumer Staples Sector SEC Filings — March 16, 2026

16-03-2026

Benchmark Electronics, Inc. announced that its Board of Directors declared a quarterly dividend of $0.17 per share on March 16, 2026. The dividend is payable on April 10, 2026, to shareholders of record at the close of business on March 31, 2026.

• ·Filing includes Exhibit 99.1: Press release dated March 16, 2026

16-03-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on March 16, 2026, announcing via attached press release (Exhibit 99.1) the cancellation of a previously proposed increase in authorized shares following a reverse stock split. The disclosure is furnished under Item 8.01 and not deemed 'filed' for liability purposes. The report was signed by CEO Steven Reinharz.

16-03-2026

CoStar Group, Inc. (NASDAQ: CSGP) appointed Nana Banerjee as a new independent director to its Board of Directors, effective immediately on March 16, 2026, expanding the board to nine members with eight independent directors. Banerjee brings over two decades of experience in leading technology, data, AI, and analytics businesses from roles including CEO of Pelmorex Corp., Senior Managing Director at Cerberus Capital Management, and CEO of McGraw-Hill. The appointment supports the company's long-term growth strategy in AI and advanced analytics, as stated by CEO Andy Florance and Board Chair Louise Sams.

• ·CoStar Group’s websites attracted over 139 million average monthly unique visitors in the fourth quarter of 2025.
• ·Founded in 1986 and headquartered in Arlington, Virginia.

16-03-2026

On February 17, 2026, Addentax Group Corp. agreed to purchase 34,200,000 common shares of KEEMO Fashion Group Limited from Guang Wen Global Group Limited for approximately $5.5 million, with payment via transfer of a portion of an existing $17.5 million bond issued on August 24, 2023. The transaction is expected to close by May 1, 2026, making Addentax the controlling shareholder with approximately 62.18% of voting rights on a fully-diluted basis. This 8-K/A filing amends a prior version solely to correct a typographical error in the seller's name.

• ·Bond bears 2.5% interest per annum with one-year tenor (renewable), governed by New York law
• ·Stock Purchase Agreement dated February 17, 2026; Bond Transfer Agreement dated February 18, 2026

16-03-2026

KORU Medical Systems, Inc. announced the retirement of CEO Linda Tharby effective June 30, 2026, with Adam Kalbermatten appointed as President effective March 15, 2026, and succeeding as CEO on July 1, 2026. Tharby will serve as a non-executive advisor and Board member through December 31, 2026, receiving continued base salary at 50% rate during the advisory period and specific equity vesting, while some PSUs were previously cancelled. Kalbermatten's compensation includes base salary increasing to $525,000 and significant LTI awards totaling up to $1.25M annually.

• ·Tharby ineligible for bonus/incentives post-June 30, 2026; remaining unvested awards forfeited after Dec 31, 2026 except specified tranches.
• ·Kalbermatten eligible for severance including 12 months salary continuation and 100% bonus target upon qualifying termination.
• ·Tharby non-compete and restrictive covenants remain in effect; no equity sales during advisory period without Board approval.

16-03-2026

Mountain Crest Acquisition Corp. V reported a widened net loss of $431,161 for the year ended December 31, 2025, up 15% YoY from $374,454 in 2024, driven by sharply lower interest income on the Trust Account ($46,114 vs. $265,306). While general and administrative expenses declined 24% to $471,782 and net cash used in operating activities improved to $742K from $921K, total assets fell to $874K from $1.3M, cash dropped to $12K, and the Trust Account balance decreased 27% to $841K amid ongoing redemptions reducing redeemable shares to 72,123 from 101,104. Stockholders' deficit worsened to $(3.7M) from $(3.4M), with related-party promissory note rising to $1.3M.

• ·Proposal to amend Charter to extend Combination Period to November 16, 2024 with $0.10 per Public Share deposits for three-month extensions.
• ·Deferred underwriting commission obligation of $2.07M upon business combination.
• ·Conversion of $600K related-party promissory note to equity in 2024.
• ·Reversal of $194K excise tax payable in 2025.
• ·Net cash provided by investing activities $363K in 2025 (vs $4.72M in 2024), mainly from $336K redemption withdrawals.

16-03-2026

Surf Air Mobility Inc. (SRFM) filed a Form S-3 shelf registration statement on March 13, 2026, for the resale of up to 6,131,995 shares of common stock by selling stockholders, with the company bearing registration costs but receiving no proceeds. The filing confirms SRFM's status as an emerging growth company and smaller reporting company, with common stock listed on NYSE (SRFM) closing at $1.88 per share on March 12, 2026. Corporate governance includes restrictions limiting Non-Citizens to 25.0% of voting interest and 49.0% of equity securities.

• ·Permitted Holders (Kuzari Investor 94647 LLC, Sudhin Shahani, Liam Fayed and affiliates) retain voting rights if Non-Citizen ownership exceeds 25.0%, reduced pro rata.
• ·Registrant classified as non-accelerated filer, smaller reporting company, and emerging growth company.
• ·Principal executive offices: 12111 Crenshaw Blvd., Hawthorne, CA 90250.

16-03-2026

OPAL Fuels reported Q4 2025 revenue of $99.8 million, up 25% YoY, and full-year 2025 revenue of $349.0 million, up 16% YoY, with RNG production increasing 20% to 1.3 million MMBtu in Q4 and 29% to 4.9 million MMBtu for the year. Adjusted EBITDA rose 51% YoY to $34.2 million in Q4 but was flat at $90.2 million for the full year; however, Renewable Power revenue declined 10% YoY to $8.6 million in Q4 and 27% to $32.8 million annually, while total Fuel Station Services volumes fell 1% to 41.3 million GGEs in Q4.

• ·2026 Adjusted EBITDA guidance: $95M to $110M, assuming average D3 RIN price of $2.45/gallon and RNG production of 5.4 to 5.8 million MMBtu.
• ·Liquidity improved to $181.7M as of March 10, 2026.
• ·Capital expenditures declined to $70.7M in 2025 from $127.2M in 2024.
• ·$120M issued from new $180M preferred facility used partly to redeem prior Series A Preferred Units.

16-03-2026

Relay Therapeutics, Inc. announced data from the Phase 1/2 ReDiscover trial of zovegalisib (RLY-2608) in combination with fulvestrant at the recommended Phase 3 dose (400mg BID fed) in PI3Kα-mutated, HR+/HER2- metastatic breast cancer patients, presented at the European Society for Medical Oncology Targeted Anticancer Therapies Congress 2026. As of the January 13, 2026 data cut-off, among 57 efficacy-evaluable patients (all prior CDK4/6 and endocrine therapy), median PFS was 11.1 months (11.2 months in kinase mutations n=33, 11.0 months in non-kinase n=24), with confirmed ORR of 43% (15/35 measurable disease; 52% or 11/21 in second-line only). The regimen was generally well-tolerated with low-grade, manageable TRAEs, consistent with prior data, majority Grade 1 hyperglycemia, and only 4/60 discontinuations due to TRAEs.

• ·Median follow-up: 12.0 months
• ·Median PFS 95% CI: 7.3–13.0 months
• ·Pharmacokinetic exposures comparable to prior 600mg BID fasted dose, approaching IC90 in majority and above IC80 throughout dosing interval
• ·Safety profile consistent with prior 600mg BID fasted data; no Grade 4-5 hyperglycemia; Grade 2/3 hyperglycemia mostly in pre-diabetic patients at baseline
• ·Data cut-off date: January 13, 2026
• ·Filing date: March 16, 2026

16-03-2026

Black Diamond Therapeutics achieved net income of $22.4M in 2025, reversing a $69.7M loss in 2024, fueled by $70M in new license revenue and sharp cuts in operating expenses (R&D down 35% to $33.6M, G&A down 40% to $16.6M). However, cash and equivalents fell 42% to $21.0M amid a $44.9M outflow in investing activities, and the company recorded a $7.3M impairment charge. Total assets expanded 17% to $143.0M, supported by investments surging 73% to $107.7M, while stockholders' equity rose 35% to $112.2M.

• ·Net income per share basic/diluted: $0.39 (2025) vs $(1.27) (2024)
• ·Weighted average shares basic: 56.9M (2025) vs 55.0M (2024)
• ·Stock-based compensation: $6.6M (2025) down from $10.6M (2024)

16-03-2026

Telos Corp (TLS) reported FY2025 revenue of $164.8M, up 52% YoY from $108.3M, primarily driven by Security Solutions segment growth of 95% to $149.6M, while Secure Networks segment revenues declined 52% to $15.2M. Gross margin improved to 37.0% from 31.8%, Adjusted EBITDA turned positive at $18.1M versus -$9.6M prior year, and operating cash flow swung to $30.2M from -$25.9M; however, the company recorded a net loss of $36.5M (improved from $52.5M), including a $14.9M goodwill impairment.

• ·Products revenue grew to $28.3M from $4.7M YoY.
• ·Services revenue increased to $136.5M from $103.6M YoY.
• ·Basic and diluted EPS improved to -$0.50 from -$0.73.
• ·Net cash used in investing activities $8.9M (improved from $16.8M).

16-03-2026

Gilat Satellite Networks Ltd reported FY2025 revenues of $451.7M, up 48% YoY from $305.4M, with strong growth in Gilat Commercial (+81% to $281.4M) and Gilat Peru (+33% to $69.9M), while Gilat Defense grew modestly 3% to $100.4M. However, gross profit margins declined to 30% from 37% (absolute gross profit +30% to $133.3M), primarily due to lower margins in Commercial (27% vs 48%) from the SBS acquisition and intangible amortization, and operating expenses rose 28% to $109.9M. Cash from operations decreased to $20.7M from $31.7M, though ending cash and equivalents rose to $169.0M after strong financing inflows.

• ·Research and development expenses, net up 22% YoY to $46.7M.
• ·Selling and marketing expenses up 28% YoY to $35.1M.
• ·General and administrative expenses up 17% YoY to $31.3M.
• ·Other operating income, net decreased 53% to $3.2M.
• ·Net cash used in investing activities $136.4M (vs $6.6M in 2024).
• ·Net cash from financing activities $163.2M (vs -$8.1M in 2024).

16-03-2026

IPG Photonics Corporation announced via press release that the Local Division of the Unified Patent Court in Dusseldorf, Germany, issued a decision on March 16, 2026, in a previously disclosed patent infringement lawsuit brought by affiliates of Trumpf SE & Co. KG against IPG Laser GmbH & Co. KG, the Company's German subsidiary. The press release is attached as Exhibit 99.1. No financial impact or specific details on the decision outcome were disclosed in the filing.

16-03-2026

Rafael Holdings reported a Q2 FY2026 net loss of $6.4M ($0.13/share), wider than $4.6M ($0.19/share) YoY due to sharply higher R&D expenses of $4.5M from Cyclo Therapeutics consolidation, though G&A fell to $2.3M and revenue rose to $211k. For the first half FY2026, net loss widened to $16.2M from $13.6M YoY with R&D at $12.0M versus flat G&A of $5.1M and revenue up to $451k; cash was $37.8M, down from $52.8M at FY2025 end. Positive progress noted on the Phase 3 TransportNPC™ study for Trappsol® Cyclo™, with top-line results expected in Q3 2026.

• ·Cyclo Therapeutics acquired in March 2025, leading to consolidation of its expenses.
• ·Data Monitoring Committee recommended continuing Phase 3 trial after 48-week review.
• ·Total current assets $42.4M as of Jan 31, 2026 vs $56.7M as of Jul 31, 2025.

16-03-2026

Comtech reported Q2 FY26 net sales of $106.8 million, down 15.6% YoY from $126.6 million, primarily due to strategic elimination of low-margin products and U.S. government shutdown impacts, with S&S segment sales declining 31.3% to $50.6 million. However, gross profit rose to $36.2 million (33.9% margin vs. 26.7% prior), Adjusted EBITDA increased 214% to $9.1 million, operating loss narrowed to $1.2 million from $10.3 million, net bookings surged 120.9% to $175.4 million (1.64x book-to-bill), and backlog reached $731.6 million. Allerium segment sales grew 6.2% YoY to $56.2 million, while the company generated $4.9 million in operating cash flow and ended with $49.9 million liquidity.

• ·S&S book-to-bill ratio improved slightly to 0.68x from 0.64x YoY.
• ·Allerium book-to-bill ratio 2.51x vs. 0.61x YoY.
• ·Backlog decreased to $731.6M from $763.8M YoY but up from $672.1M prior quarter.
• ·Ongoing litigation with former CEO Ken Peterman via American Arbitration Association.

16-03-2026

Universal Logistics Holdings, Inc. (ULH) reported 2025 operating revenues of $1.56B, down 15.6% YoY from $1.85B in 2024, swinging to a net loss of $99.9M (-6.4% margin) from $129.9M profit (7.0% margin), driven by a $124M impairment expense and a $162M operating loss in Intermodal (vs -$28M prior). While Value-Added services rose to 45.7% of revenues (from 42.6%) and Dedicated services to 21.7% (from 18.6%), Brokerage services plunged to 4.7% (from 9.8%) and Intermodal revenues fell to $257M (from $309M). In 2024, revenues had grown 11.1% YoY from $1.66B with net income up 39.8% to $129.9M.

• ·2025 EPS basic and diluted: -$3.79 (vs $4.94 in 2024)
• ·Dividends per share flat at $0.42 across 2023-2025
• ·Goodwill declined to $106M in 2025 from $207M in 2024
• ·Total stockholders' equity down to $540M from $647M
• ·Intermodal revenues down 16.7% YoY to $252M in detailed service breakdown

16-03-2026

Motorsport Games Inc. filed a DEF 14A proxy statement seeking shareholder approval for the election of John Delta and Guoquan (Paul) Huang as Class II directors for a two-year term expiring at the 2028 Annual Meeting. The Board consists of four members, with Class I directors Andrew P. Jacobson and Navtej Singh Sunner continuing until the 2027 Annual Meeting. No financial performance data or period comparisons are disclosed in the filing.

• ·Stockholder proposals for inclusion in 2027 proxy materials due by November 16, 2026.
• ·Advance notice for 2027 Annual Meeting director nominations: 60-90 days before first anniversary of prior meeting.
• ·Rule 14a-19 notice for alternative director nominees due by February 16, 2027.
• ·Guoquan (Paul) Huang appointed to Board pursuant to Purchase Agreement dated April 11, 2026.
• ·Company address: 3350 SW 148th Avenue, Suite 207, Miramar, Florida 33027; Phone: (305) 413-0812.

16-03-2026

Honeywell Aerospace Inc. entered into a Registration Rights Agreement dated March 16, 2026, with representatives Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC, covering $16B aggregate principal amount of Senior Notes issued pursuant to a Purchase Agreement dated March 10, 2026. This includes $10B in new money notes (various tranches maturing 2028-2036) issued by the Company and $6B in exchange notes (maturing 2046-2066) sold by selling securityholders, all guaranteed by Honeywell International Inc. The agreement mandates a Registered Exchange Offer to be completed no later than 365 days after the Honeywell Aerospace Spin-Off or related successor assumption.

• ·Registered Exchange Offer must be completed no later than 60 days after Exchange Offer Registration Statement effectiveness, but no later than 365 days after Honeywell Aerospace Spin-Off consummation or successor assumption under Indenture Article 10.
• ·Exchange Offer open for not less than 20 Business Days.
• ·Securities issued under Base Indenture and First Supplemental Indenture, both dated March 16, 2026.

16-03-2026

DiamondRock Hospitality Company filed definitive additional proxy materials (DEFA14A) on March 16, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. This supplement provides updated information required in proxy statements under Schedule 14A, with no fee required for filing. No specific proposals, financial data, or changes are detailed in the provided header content.

16-03-2026

Dell Technologies Inc. reported FY2026 total net revenue of $113.5B, up 19% YoY from $95.6B, driven by strong 27% growth in Products to $90.4B, though Services revenue declined 4% to $23.1B. Operating income increased 31% to $8.1B and net income rose 30% to $5.9B, with cash flow from operations surging 147% to $11.2B; however, product gross margin compressed to 13.7% from 15.8% YoY and total gross margin fell to 20.0% from 22.2%. Non-GAAP diluted EPS grew 27% to $10.30, while the company repurchased 14.9M shares.

• ·Share repurchases: 3.3M shares at $133.22 avg (Nov 1-28, 2025), 3.6M at $132.34 (Nov 29-Dec 26, 2025), 8.0M at $118.96 (Dec 27, 2025-Jan 30, 2026).
• ·Remaining share repurchase authorization: $5,798M as of Jan 30, 2026.
• ·Related party cost of net revenue in FY2024: $1,010M (Products), $2,810M (Services).

16-03-2026

FutureFuel Corp. reported a sharp 61% YoY revenue decline to $95.7M in FY 2025 (ended Dec 31, 2025) from $243.3M in FY 2024, driven by operational challenges, resulting in a net loss of $49.4M versus net income of $15.5M and Adjusted EBITDA loss of $38.3M compared to $21.3M profit. Operating income swung to a $53.0M loss from $6.4M profit, with cash used in operations at $28.7M versus $24.8M provided. Despite the downturn, the company declared an initial quarterly dividend of $0.06 per share for Q1 2026 and emphasized chemicals segment expansion through vertical integration.

• ·Depreciation expense increased slightly 5% YoY to $9.7M in FY 2025 from $9.2M.
• ·Turnaround costs remained relatively flat at $3.8M in FY 2025 versus $3.7M in FY 2024.
• ·Company does not report backlog, relying on long-term contract stability instead.
• ·Filing date: March 16, 2026

16-03-2026

Douglas Elliman Inc. achieved 4% YoY revenue growth to $1.03B in FY2025, flipping to net income of $15.2M (1.47% margin) from a $76.3M loss (-7.67% margin) in 2024, bolstered by an $81.7M gain on business disposal, absence of prior-year antitrust settlement, and higher Gross Transaction Value of $39.8B (up 9%). However, total transactions declined slightly 2% YoY to 21,338, principal agents dropped sharply 15% to 4,492 with retention falling to 84% from 89%, and Adjusted EBITDA remained negative at -$14.0M despite improvement from -$24.1M. Operating cash flow used $13.9M, down from $26.0M, while cash and equivalents fell to $115.5M from $135.7M.

• ·Total assets declined to $444.4M from $493.9M YoY.
• ·Stockholders' equity rose to $183.3M from $162.4M.
• ·Antitrust litigation settlement liability reduced to $5.0M from $10.0M.
• ·Operating lease right-of-use assets down to $83.3M from $100.5M.
• ·Convertible debt related items extinguished, notes payable to $0 from $32.7M.

16-03-2026

Barnwell Industries, Inc. (BRN) announced on March 11, 2026, the appointment of Sean Wallace as a strategic advisor to the Company, as detailed in a press release filed as Exhibit 99.1. The 8-K filing was submitted on March 16, 2026, under Items 8.01 and 9.01. No financial metrics or performance data were disclosed.

• ·Filing incorporates press release as Exhibit 99.1 dated March 11, 2026
• ·Registrant details: Delaware incorporation, Commission File Number 1-5103, IRS EIN 72-0496921, headquartered at 24 Greenway Plaza, Suite 1800Q, Houston, Texas 77046
• ·Common Stock ($0.50 Par Value) trades as BRN on NYSEAMER

16-03-2026

DuPont de Nemours, Inc. announced it expects to close the previously disclosed sale of its aramids business, including Kevlar® and Nomex®, to Arclin on April 1, 2026, after all regulatory conditions were satisfied as of March 10, 2026. The filing includes forward-looking statements noting risks that could impact the transaction timing or completion, such as unforeseen liabilities or business disruptions.

• ·Aramids business sale regulatory conditions satisfied on March 10, 2026
• ·Information furnished under Item 7.01, not deemed filed under Section 18 of the Exchange Act

16-03-2026

Moderna, Inc. filed Definitive Additional Proxy Soliciting Materials (DEFA14A) on March 16, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing appears to include a notice of internet availability of proxy materials (image reference: a2026noticeandaccess_1a.jpg), with no specific proposals, financial data, or performance metrics disclosed in the text.

• ·CIK: 0001682852
• ·EIN: 813467528
• ·SIC: 2836 (Biological Products)
• ·Business address: 325 Binney Street, Cambridge, MA 02142
• ·Business phone: 617-714-6500
• ·Fiscal year end: December 31
• ·SEC file number: 001-38753
• ·State of incorporation: Delaware
• ·Former name change: Moderna Therapeutics, Inc. to Moderna, Inc. on August 22, 2016

16-03-2026

Pebblebrook Hotel Trust announced on March 16, 2026, quarterly cash dividends for its common shares at $0.01 per share and preferred shares including Series E ($0.39844), Series F ($0.39375), Series G ($0.39844), and Series H ($0.35625) per share, all payable on April 15, 2026, to holders of record as of March 31, 2026. These preferred dividends reflect their fixed annual rates of 6.375%, 6.30%, 6.375%, and 5.70% respectively on the $25 per share liquidation preference. No changes from prior declarations are indicated in the filing.

• ·Common Dividend for quarter ending March 31, 2026
• ·All dividends declared by Board of Trustees on March 16, 2026
• ·Securities traded on New York Stock Exchange under symbols PEB, PEB-PE, PEB-PF, PEB-PG, PEB-PH

16-03-2026

Helmerich & Payne, Inc. (NYSE: HP) announced executive leadership updates following Trey Adams’ appointment as President and CEO on March 4, 2026, including the retirement of SVP and CFO Kevin Vann effective June 30, 2026, and the appointment of Todd Scruggs as new SVP and CFO effective July 1, 2026. Vann will serve as a senior advisor through December 31, 2026, to ensure a smooth transition while the company advances KCA Deutag integration and strategic priorities. The changes highlight internal leadership strength and continuity amid de-leveraging and operational improvements.

• ·Scruggs joined H&P in 2024 after serving as Partner at Veriten, with prior roles enhancing treasury, FP&A, capital allocation, and portfolio optimization.
• ·Fleet totals 345 land rigs (203 US, 137 international) and 5 offshore platform rigs as of February 4, 2026.

16-03-2026

Claritev Corporation (CTEV) hosted its 2026 Investor Day on March 16, 2026, in New York, with the slide presentation furnished as Exhibit 99.1 under Item 7.01 to comply with Regulation FD. The disclosure is not deemed 'filed' for purposes of Section 18 of the Exchange Act or incorporated by reference into other filings. No specific financial metrics, performance data, or period-over-period comparisons were detailed in the filing.

• ·Principal executive offices: 7900 Tysons One Place, Suite 400, McLean, Virginia 22102; Telephone: (212) 780-2000
• ·Securities: Shares of Class A Common Stock, $0.0001 par value per share (CTEV) on New York Stock Exchange
• ·Incorporation: Delaware; Commission File Number: 001-39228; IRS EIN: 84-3536151

16-03-2026

On March 10, 2026, the Compensation Committee of Kestrel Group Ltd approved restricted share awards (RSAs) of $650,000 each to Mr. Terry Ledbetter, Mr. Bradford Ledbetter, and Mr. Haveron for fiscal year 2026 under the 2025 Equity Incentive Plan. The Committee also approved catch-up RSAs of $1,300,000 each to the same executives for fiscal year 2025, which were not previously granted. These awards are scheduled for grant on March 18, 2026, and Mr. Haveron's prior performance-based equity awards from Maiden Holdings, Ltd. were cancelled as they were no longer capable of vesting.

• ·FY2025 RSAs vest in substantially equal installments: first on grant date (March 18, 2026), remaining on first two anniversaries.
• ·FY2026 RSAs vest in substantially equal installments on the first three anniversaries of the grant date (March 18, 2026).
• ·Description of RSAs qualified by reference to Exhibit 10.1 in Form 10-Q for quarter ended September 30, 2025.

16-03-2026

Oshkosh Corporation entered into a Fourth Amended and Restated Credit Agreement on March 16, 2026, establishing an unsecured revolving credit facility of $1.6 billion maturing in March 2031, up from the prior $1.55 billion facility dated March 23, 2022. The new agreement allows for potential increases of up to $800 million subject to conditions and includes covenants such as a maximum leverage ratio of 3.75:1 (temporarily up to 4.25:1 post-acquisitions). Additionally, the company amended its $500 million term loan credit agreement dated March 31, 2025, to align terms with the new revolving facility.

• ·Credit facility matures in March 2031.
• ·Maximum leverage ratio covenant: 3.75 to 1.00, temporarily increasable to 4.25 to 1.00 post-material acquisitions.
• ·Interest rates based on Term SOFR, base rate, SONIA, EURIBOR, etc., with adjustable margins.

16-03-2026

RedCloud Holdings plc (RCT) filed an F-1 registration statement on March 16, 2026, for an initial public offering, providing financial data through June 30, 2025 (H1 FY25), including balance sheet items like common stock, additional paid-in capital, merger reserve, retained earnings, and capitalized software development. The filing discloses operations across geographies such as Nigeria (NG), Argentina (AR), UK (GB), with details on unsecured shareholder term loans, convertible loan agreements (including Tranches One and Two from 2024), and related party transactions; no numerical values are specified in the provided excerpt, limiting period-over-period analysis. It highlights a merger involving RedCloud Technologies Limited and ongoing debt facilities, positioning the company for public listing.

• ·Geographical operations include Nigeria (NG), Argentina (AR), UK (GB), South Africa (ZA), Portugal (PT), and other foreign entities.
• ·Accounts receivable aging categories detailed for periods ending 2025-06-30, 2024-12-31, and 2023-12-31.
• ·Fixed assets include computer equipment and office equipment with depreciation periods.
• ·Convertible loans include Tranche One (drawn Feb 8, 2024) and Tranche Two (Mar 26, 2024).
• ·Unsecured shareholder term loans with multiple drawdowns through 2025-01-31.
• ·Management consultancy agreement with Justin Floyd ongoing from 2019.

16-03-2026

16-03-2026

Dennis J. Wilson and affiliated Reporting Persons filed Amendment No. 15 to Schedule 13D on March 16, 2026, reporting no change in beneficial ownership of lululemon athletica inc. common stock since Amendment No. 14 filed March 9, 2026, with Wilson directly linked to 8.4% ownership and affiliates holding additional stakes totaling approximately 8-9% combined. On March 12, 2026, Wilson issued a press release containing a letter to potential CEO candidates criticizing the Board as unfit, calling for refreshment to support visionary leadership, and raising questions on independence, innovation investment, and internal talent development.

• ·Original Schedule 13D filed February 14, 2019
• ·House of Wilson Ltd., Laura Gentile, Eric Hirshberg, and Marc Maurer each report 0.0% ownership

16-03-2026

flyExclusive Inc. (FLYX-WT) filed an amended S-4 registration statement on March 16, 2026, primarily referencing financial instruments such as multiple notes payable to banks (e.g., Financial Institution One through Eight), senior secured notes to related parties like LGM Enterprises LLC, Series A and B preferred stock, private placement and public warrants, and lines of credit secured by aircraft assets including HondaJets and Gulfstream GIVs. The document covers balance sheets as of December 31, 2025, and 2024, with related party transactions involving subsidiaries like Carolina Air Center LLC, Crystal Coast Aviation LLC, and Kinston Jet Center LLC, but no specific financial performance metrics or period-over-period changes are detailed. Subsequent events include an At The Market Offering Agreement with Lucid Capital Markets LLC on February 10, 2026, and common stock issuances on February 16 and 18, 2026.

• ·Balance sheet dates: 2025-12-31 and 2024-12-31
• ·Subsequent events: 2026-02-10 (Lucid Capital Markets agreement), 2026-02-16 (senior notes), 2026-02-18 (LGM Enterprises common stock)
• ·Various loan origination dates including 2025-07-31 (merchant cash advance), 2025-04-30 (notes payable), 2024-03-04 (Series A preferred stock private placement)

16-03-2026

Regis Corporation announced leadership transitions with Susan Lintonsmith appointed as President and Chief Executive Officer, Jim Lain transitioning from Interim CEO to Chief Operating Officer, Nancy Benacci named Chair of the Board, and Andrew Alfano appointed as an independent director. These changes are positioned to enhance operational excellence and accelerate growth in the company's franchised haircare business, which includes 3,829 locations as of December 31, 2025. No financial impacts or performance metrics were disclosed in the announcement.

• ·Board of Directors now consists of five independent directors and Susan Lintonsmith.
• ·Jim Lain joined Regis in 2013 with over 30 years of operations experience.
• ·Susan Lintonsmith has over 35 years of senior leadership experience.

16-03-2026

Monroe Capital Corporation (MRCC) issued a press release on March 16, 2026, announcing that shareholders approved all proposals submitted to a vote at the company's special meeting of shareholders held on March 13, 2026. The disclosure is furnished under Regulation FD and includes Exhibit 99.1 as the press release. No financial metrics or performance data were disclosed in the filing.

• ·Filing includes Exhibit 99.1: Press Release dated March 16, 2026
• ·Registrant details: Maryland incorporation, Commission File Number 814-00866, IRS EIN 27-4895840
• ·Principal executive offices: 155 North Wacker Drive, 35th Floor, Chicago, Illinois 60606

16-03-2026

Allegiant Travel Company announced on March 16, 2026, the early termination of the HSR Act waiting period for its proposed merger with Sun Country Airlines Holdings, Inc., a key regulatory milestone following the merger agreement entered on January 11, 2026. The transaction involves the First Merger of Mirage Merger Sub, Inc. with Sun Country, followed by the Second Merger with Sawdust Merger Sub, LLC, making Sun Country a wholly owned subsidiary of Allegiant. A joint press release was issued as Exhibit 99.1.

16-03-2026

Elicio Therapeutics, Inc. entered into an At Market Issuance Sales Agreement dated March 16, 2026, with B. Riley Securities, Inc., JonesTrading Institutional Services LLC, and Ladenburg Thalmann & Co. Inc., enabling the company to issue and sell shares of its common stock (par value $0.01 per share) from time to time through the agents as principals or sales agents. Sales are capped at the Maximum Amount, defined as the lesser of limits under the effective Form S-3 registration statement (File No. 333-293861), prospectus supplement, authorized but unissued shares, and Form S-3 General Instruction I.B.6. No specific aggregate dollar amount or share volume was disclosed, and no sales have occurred under the agreement as of the filing.

• ·Agreement filed as Exhibit 10.1 to 8-K.
• ·Sales to be effected pursuant to Registration Statement on Form S-3 (File No. 333-293861).
• ·Agents to receive compensation per Schedule 2 (details not specified in excerpt).

16-03-2026

Credit Suisse High Yield Credit Fund (NYSE American: DHY) has issued a proxy statement for its Annual Meeting of Shareholders on April 21, 2026, at 4:00 p.m. ET, to elect two Non-Interested Trustees, Charles W. Gerber and Samantha Kappagoda, each for a three-year term expiring in 2029. The record date is March 12, 2026, with 103,609,624 shares outstanding entitled to vote. The Board recommends voting 'FOR' both nominees, who are unopposed.

• ·Annual Meeting location: offices of UBS AM (Americas), Eleven Madison Avenue (between East 24th and 25th Streets), Floor 2B, New York, New York 10010
• ·Fund fiscal year end: October 31
• ·Fund's Annual Report for fiscal year ended October 31, 2025 available upon request or at https://us-fund.ubs.com/en/home
• ·Proxy materials first mailed to shareholders on or about March 19, 2026
• ·Filing date: March 16, 2026

16-03-2026

The Coca-Cola Company issued a DEFA14A filing notice for its 2026 Annual Meeting of Shareowners on April 29, 2026, at 8:30 a.m. ET, held virtually at meetnow.global/KO2026. The Board recommends voting FOR electing 12 director nominees, an advisory vote approving executive compensation, and ratifying Ernst & Young LLP as auditors for 2026, but AGAINST five shareholder proposals on a sustainability committee, plastics packaging policies, DEI efforts, ingredient risks, and sustainability disclosure plans. Proxy materials and the 2025 Form 10-K are available at www.envisionreports.com/coca-cola, with paper copy requests due by April 19, 2026.

• ·Virtual meeting access requires control number in white circle on notice
• ·Requests for proxy materials via internet (www.envisionreports.com/coca-cola), phone (1-866-641-4276), or email (investorvote@computershare.com)
• ·Votes must be cast online or via requested paper proxy card; notice itself cannot be used to vote